Page last updated: 2024-09-04

moxifloxacin and triclabendazole

moxifloxacin has been researched along with triclabendazole in 1 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (triclabendazole)	Trials (triclabendazole)	Recent Studies (post-2010) (triclabendazole)
3,157	552	1,690	497	44	209

Protein Interaction Comparison

Protein	Taxonomy	moxifloxacin (IC50)	triclabendazole (IC50)
Transthyretin	Homo sapiens (human)		3.5

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gray, C; Iyer, GR; Lecot, J; Prince, WT; Shakeri-Nejad, K; Taylor, A; Venishetty, VK; Zack, J	1

Trials

1 trial(s) available for moxifloxacin and triclabendazole

Article	Year
Effects of triclabendazole and its metabolite exposure on the heart-rate-corrected QT intervals: A randomized, placebo- and positive-controlled thorough QT study in healthy individuals. Clinical and translational science, 2023, Volume: 16, Issue:10 Topics: Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Fluoroquinolones; Healthy Volunteers; Heart Rate; Humans; Moxifloxacin; Triclabendazole	2023

Article

Year

Effects of triclabendazole and its metabolite exposure on the heart-rate-corrected QT intervals: A randomized, placebo- and positive-controlled thorough QT study in healthy individuals.

Clinical and translational science, 2023, Volume: 16, Issue:10

Topics: Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Fluoroquinolones; Healthy Volunteers; Heart Rate; Humans; Moxifloxacin; Triclabendazole

2023